BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/28/2021 9:42:07 AM | Browse: 550 | Download: 926
 |
Received |
|
2021-04-10 01:02 |
|
Peer-Review Started |
|
2021-04-10 01:02 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-04-28 22:08 |
|
Revised |
|
2021-05-11 07:33 |
|
Second Decision |
|
2021-06-22 14:09 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2021-06-22 14:38 |
|
Articles in Press |
|
2021-06-22 14:38 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2021-06-24 01:43 |
|
Typeset the Manuscript |
|
2021-06-28 01:06 |
|
Publish the Manuscript Online |
|
2021-06-28 09:42 |
| ISSN |
2644-3228 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Minireviews |
| Article Title |
Therapeutic tumor vaccines — a rising star to benefit cancer patients
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Qian Wei, Zhao-Yuan Fang, Zi-Meng Zhang and Teng-Fei Zhang |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Teng-Fei Zhang, MD, Associate Professor, Department of Oncology, The First Affiliated Hospital of Zhengzhou University, No. 1 Eastern Jianshe Road, Zhengzhou 450052, Henan Province, China. fcczhangtf@zzu.edu.cn |
| Key Words |
Tumor vaccines; Tumor cell vaccines; Dendritic cell vaccines; Peptide vaccines; Nucleic acid vaccines |
| Core Tip |
There are many advancements in the field of cancer immunotherapy in the past decade such as the application of immune checkpoint blockade and adoptive cell therapy. Tumor therapeutic vaccines have emerged as an additional effective treatment strategy due to their ability to trigger potent immune response. Typically, they are tumor cell vaccines, dendritic cell vaccines, peptide vaccines or nucleic acid vaccines. This article mainly reviews the current clinical status as well as research and development status of these four types of therapeutic tumor vaccines for those who are interested. |
| Publish Date |
2021-06-28 09:42 |
| Citation |
Wei Q, Fang ZY, Zhang ZM, Zhang TF. Therapeutic tumor vaccines — a rising star to benefit cancer patients. Artif Intell Cancer 2021; 2(3):25-41 |
| URL |
https://www.wjgnet.com/2644-3228/full/v2/i3/25.htm |
| DOI |
https://dx.doi.org/10.35713/aic.v2.i3.25 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
